MM
Mathew S. Maurer
Highly rated in
24
conditions
Highly rated in
24
conditions
Check Dr. Mathew S. Maurer's experience treating your condition:
About Dr. Mathew S. Maurer

Mathew Maurer is a Cardiologist in New York, New York. Maurer has been practicing medicine for over 31 years and is highly rated in 24 conditions, according to our data. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Aortic Valve Replacement. He is licensed to treat patients in New York. Maurer is currently accepting new patients.

His clinical research consists of co-authoring 335 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mathew S. Maurer it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Mathew S. Maurer accepts the following insurance:

  •  Ambetter
Locations
173 Fort Washington Ave, New York, NY 10032
Other Locations
622 W 168th St, New York, NY 10032
Background & Education
Graduate Institution
Icahn School Of Medicine At Mount Sinai, 1992
Specialties
Cardiology
Licenses
Internal Medicine in NY
Hospital Affiliations
NewYork-Presbyterian/Weill Cornell Medical Center
NewYork-Presbyterian/Columbia University Irving Medical Center
Greenwich Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Impact of a High Energy and High Protein Nutrition Supplementation Intervention on Outcomes in Patients With Advanced Heart Failure
Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Transthyretin Amyloid (ATTR) Cardiomyopathy
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Effects of Home-delivered Low-sodium Meals in Older Adults Following Heart Failure Hospitalization.
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors